Sevelamer Doesn't Protect the Heart in Early CKD: StudySevelamer Doesn't Protect the Heart in Early CKD: Study

The phosphate binder sevelamer didn't have any favorable cardiovascular effects in a randomized controlled trial of patients with stage 3 chronic kidney disease (CKD). Reuters Health Information
Source: Medscape Nephrology Headlines - Category: Urology & Nephrology Tags: Cardiology News Source Type: news